Fishman Corey N.

CIK 00015535944 companiesMORRISTOWN, NJ

SEC Profile

Transactions

Companies

Filings

CIK

0001553594

Recent Transactions

50 trades

Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+82,613→ 82,613 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2024-08-06+82,613→ 137,062 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+82,613→ 82,613 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Subscription Rights (right to buy)
2024-08-06−165,226→ 0 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-11-20$1.59/sh+10,000→ 54,449 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2023-03-31+275,000→ 275,000 total
Tax Payment
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-03-11$0.96/sh−5,683→ 44,449 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-03-11+14,333→ 50,132 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-03-11−14,333→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-03-11−215,000→ 215,000 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2022-03-11+215,000→ 537,008 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2021-06-23+5,280,000→ 5,280,000 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2021-03-11+430,000→ 430,000 total
Sale
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-01-26$1.73/sh−85,445→ 322,008 total
Award
Iterum Therapeutics plc$ITRM
Ordinary Shares
2021-01-25+167,500→ 407,453 total
Disposition to Issuer
BIOSPECIFICS TECHNOLOGIES CORP
Common Stock, $0.001 par value
2020-12-02−2,018→ 0 total
Disposition to Issuer
BIOSPECIFICS TECHNOLOGIES CORP
Stock Option (Right to Buy)
2020-12-02$32.87/sh−6,000→ 0 total
Award
BIOSPECIFICS TECHNOLOGIES CORP
Stock Option (Right to Buy)
2020-05-01+6,000→ 6,000 total
Award
BIOSPECIFICS TECHNOLOGIES CORP
Common Stock, $0.001 par value
2020-04-13+2,018→ 2,018 total
Exercise/Conversion
MOMENTA PHARMACEUTICALS INC
Common Stock
2019-06-20+4,356→ 10,090 total
Exercise/Conversion
MOMENTA PHARMACEUTICALS INC
Restricted Stock Unit
2019-06-20−4,356→ 0 total
Award
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2019-06-19+25,000→ 25,000 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2019-02-15+150,000→ 150,000 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-08-17$8.73/sh+2,000→ 239,953 total
Exercise/Conversion
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units
2018-06-20−5,734→ 0 total
Award
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2018-06-20+8,855→ 8,855 total
Award
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units
2018-06-20+4,356→ 4,356 total
Exercise/Conversion
MOMENTA PHARMACEUTICALS INC
Common Stock
2018-06-20+5,734→ 5,734 total
Purchase
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30$13.00/sh+3,000→ 237,953 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+1,591→ 234,953 total
Conversion
Iterum Therapeutics plc$ITRM
Series A Preferred Shares
2018-05-30−33,259→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-2 Preferred Shares
2018-05-30−1,591→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Series B-1 Preferred Shares
2018-05-30−4,050→ 0 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+33,259→ 229,312 total
Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2018-05-30+4,050→ 233,362 total
Award
Iterum Therapeutics plc$ITRM
Stock Option (Right to Buy)
2018-05-24+127,307→ 127,307 total
Award
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2017-06-20+11,207→ 11,207 total
Award
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units
2017-06-20+5,734→ 5,734 total
Award
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy)
2016-09-22+33,000→ 33,000 total
Disposition to Issuer
Durata Therapeutics, Inc.
Common Stock
2014-11-17−24,941→ 0 total
Disposition to Issuer
Durata Therapeutics, Inc.
Stock Option (right to buy)
2014-11-17−21,574→ 0 total
Disposition to Issuer
Durata Therapeutics, Inc.
Stock Option (right to buy)
2014-11-17−50,000→ 0 total
Disposition to Issuer
Durata Therapeutics, Inc.
Stock Option (right to buy)
2014-11-17−218,750→ 0 total
Disposition to Issuer
Durata Therapeutics, Inc.
Stock Option (right to buy)
2014-11-17−12,500→ 0 total
Disposition to Issuer
Durata Therapeutics, Inc.
Stock Option (right to buy)
2014-11-17−110,000→ 0 total
Award
Durata Therapeutics, Inc.
Stock Option (right to buy)
2013-02-12$7.49/sh+50,000→ 302,824 total
Purchase
Durata Therapeutics, Inc.
Common Stock
2012-07-24$9.00/sh+2,500→ 24,941 total
Conversion
Durata Therapeutics, Inc.
Common Stock
2012-07-24+22,441→ 22,441 total
Conversion
Durata Therapeutics, Inc.
Series A Convertible Preferred Stock
2012-07-24−179,531→ 0 total
Purchase
Durata Therapeutics, Inc.
Series A Convertible Preferred Stock
2012-03-15$1.00/sh+51,163→ 179,531 total

Companies

Recent Filings

Address

C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR

MORRISTOWN, NJ, 07960

View on SEC.gov